Patent Assignment
Reel/Frame 033816/0866
Release of Security Interest
Recorded: 2014-09-25
Pages: 8
Assignor
KENTUCKY ECONOMIC DEVELOPMENT FINNCE AUTHORITY
Executed: 2014-09-24
Assignee
ZYNERBA PHARMACEUTICALS, INC.
712 5TH AVE, NEW YORK, NEW YORK, 10019
Covered Properties
(21)
Abuse Deterrent Transdermal Formulations of Opiate Agonists and Agonist-Antagonists
PCT:
PCT/US2011/031135 ↗
Transdermal delivery of cannabinoids
Application:
10/032,163 →
Publication:
US 2002/0111377
Transdermal Delivery of Cannabidiol
Transdermal delivery of naltrexone hydrochloride, naltrexol hydrochloride, and bis(hydroxy-methyl)propionyl-3-0 ester naltrexone using microneedles
Application:
11/812,249 →
Publication:
US 2008/0008745
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Enhancing transdermal delivery of opioid antagonists and agonists using codrugs linked to bupropion or hydroxybupropion
Prodrugs of Cannabidiol, Compositions Comprising Prodrugs of Cannabidiol and Methods of Using the Same
Methods and Compositions for Enhancing the Viability Of Microneedle Pores
Application:
12/325,919 →
Publication:
US 2009/0143762
Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Cannabinoid-Containing Compositions and Methods for Their Use
Application:
12/399,392 →
Publication:
US 2009/0247619
Abuse Deterrent Transdermal Formulations of Opiate Agonists and Agonist-Antagonists
Application:
12/412,189 →
Publication:
US 2009/0246265
Transdermal Delivery of Cannabidiol
Formulations of Cannabidiol and Prodrugs of Cannabidiol and Methods of Using the Same
Application:
12/769,519 →
Publication:
US 2010/0273895
Use of Cannabidiol Prodrugs in Topical and Transdermal Administration with Microneedles
Application:
12/873,248 →
Publication:
US 2011/0052694
Abuse Deterrent Transdermal Formulations of Opiate Agonists and Agonist-Antagonists
Transdermal Delivery of Cannabinoids
Application:
13/271,338 →
Publication:
US 2012/0034293
Cannabinoid-Containing Compositions and Methods for Their Use
Application:
13/318,208 →
Publication:
US 2012/0202891
Cannabinoid-Containing Compositions and Methods for Their Use
Application:
13/451,666 →
Publication:
US 2012/0202892
Optical Proximity Switch
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Application:
13/670,865 →
Publication:
US 2013/0123292
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 18, 2012
From: STINCHCOMB, AUDRA L.; BANKS, STAN LEE
To: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Reel/Frame 028148/0091 →
Assignment of Assignor's Interest
Apr 30, 2012
From: LYNN, AUDRA; BANKS, STAN LEE
To: ALLTRANZ INC.
Reel/Frame 028130/0063 →
Assignment of Assignor's Interest
Jun 27, 2012
From: STINCHCOMB, AUDRA LYNN; BANKS, STAN LEE
To: ALLTRANZ INC.
Reel/Frame 028450/0497 →
Assignment of Assignor's Interest
Jun 28, 2012
From: STINCHCOMB, AUDRA LYNN; BANKS, STAN LEE; GOLINSKI, MAROSLAW JERZY; HOWARD, JEFFREY LYNN
To: ALLTRANZ INC.
Reel/Frame 028460/0859 →
Corrective Assignment to Correct the the 1ST Name of the 3RD Inventor Miroslaw. Previously Recorded on Reel 028460 Frame 0859. Assignor(S) Hereby Confirms the Correct Spelling for the 3RD Inventor Is Miroslaw..
Jun 29, 2012
From: STINCHCOMB, AUDRA LYNN; BANKS, STAN LEE; GOLINSKI, MIROSLAW JERZY; HOWARD, JEFFREY LYNN
To: ALLTRANZ INC.
Reel/Frame 028488/0291 →
Assignment of Assignor's Interest
Jul 23, 2012
From: HARPER, JOHN; VINSHTOK, YEVGENIY; LEEDY, JUSTIN
To: IFM ELECTRONIC GMBH
Reel/Frame 028613/0291 →
Assignment of Assignor's Interest
Feb 1, 2013
From: STINCHCOMB, AUDRA LYNN; LI, GUOHUA; BANKS, STAN LEE; HOWARD, JEFFERY LYNN
To: ALLTRANZ INC.
Reel/Frame 029737/0094 →
Conditional Assignment
Jan 13, 2014
From: ALLTRANZ, INC.
To: KENTUCKY ECONOMIC DEVELOPMENT FINANCE AUTHORITY
Reel/Frame 031950/0443 →
Change of Name
Oct 13, 2014
From: ALLTRANZ, INC.
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 033937/0246 →
Change of Name
Dec 11, 2014
From: ALLTRANZ INC.
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 034477/0690 →
Change of Name
Dec 22, 2014
From: ALLTRANZ INC.
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 034571/0914 →
Assignment of Assignor's Interest
Dec 22, 2014
From: ZYNERBA PHARMACEUTICALS, INC.
To: BUZZZ PHARMACEUTICALS LTD.
Reel/Frame 034571/0991 →
Assignment of Assignor's Interest
Dec 23, 2014
From: ZYNERBA PHARMACEUTICALS, INC.
To: STINCHCOMB, AUDRA LYNN
Reel/Frame 034581/0065 →
Assignment of Assignor's Interest
Jun 19, 2023
From: STINCHCOMB, AUDRA L.; NALLURI, BUCHI N.
To: ALLTRANZ, LLC
Reel/Frame 063986/0951 →
Supplemental Confirmatory Grant of Security Interest in United States Patents
May 18, 2026
From: HARMONY BIOSCIENCES MANAGEMENT, INC. (F/K/A ZYNERBA PHARMACEUTICALS, INC.)
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075642/0639 →